Ticker Details
Erasca, Inc.
IPO Date:	July 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.97B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 3.76%
Avg Daily Range (30 D):	$0.71 | 4.32%
Avg Daily Range (90 D):	$0.50 | 4.93%

Institutional Daily Volume
Avg Daily Volume:	1.21M
Avg Daily Volume (30 D):	5.28M
Avg Daily Volume (90 D):	5.09M

Trade Size
Avg Trade Size (Sh.):	133
Avg Trade Size (Sh.) (30 D):	103
Avg Trade Size (Sh.) (90 D):	123

Institutional Trades
Total Institutional Trades:	960
Avg Institutional Trade:	$2.21M
Avg Institutional Trade (30 D):	$2.84M
Avg Institutional Trade (90 D):	$2.5M
Avg Institutional Trade Volume:	.31M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.21M
Avg Closing Trade (30 D):	$11.59M
Avg Closing Trade (90 D):	$7.14M
Avg Closing Volume:	559.33K

News

Jan 26, 2026 @ 12:52 PM Why Is Cancer Drug Developer Erasca Stock Trading ... Source: Vandana Singh

Jan 23, 2026 @ 9:01 PM Erasca Announces Closing of Upsized Public Offerin... Source: Globe Newswire

Jan 22, 2026 @ 1:54 AM Erasca Announces Pricing of Upsized Public Offerin... Source: Na

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Aug 13, 2025 @ 2:16 AM Erasca Narrows Loss 46% in Fiscal Q2 Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.44	$-.1	$-.44
Diluted EPS	$-.44	$-.1	$-.44
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-124.55M	$-29.09M	$-124.55M
Operating Income / Loss	$-140.91M	$-32.6M	$-140.91M
Cost of Revenue
Net Cash Flow	$6.07M	$3.58M	$6.07M
PE Ratio